Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress? (Q35022494)

5 August 2017

1 reference

title

Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress? (English)

1 reference

5 August 2017

Jantunen E

1

1 reference

5 August 2017

Anttila VJ

series ordinal

2

1 reference

5 August 2017

Ruutu T

series ordinal

3

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Bone Marrow Transplantation

5 August 2017

1 reference

5 August 2017

30

1 reference

5 August 2017

12

1 reference

5 August 2017

925-929

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703738

5 August 2017

0 references

cites work

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Invasive mold infections in allogeneic bone marrow transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Invasive aspergillosis in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Impact of previous aspergillosis on the outcome of bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Comparison of Serum Galactomannan Antigen Detection and Competitive Polymerase Chain Reaction for Diagnosing Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Itraconazole oral solution as antifungal prophylaxis in children undergoing stem cell transplantation or intensive chemotherapy for haematological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Impact of Surgical Treatment on Paranasal Fungal Infections in Bone Marrow Transplant Patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Therapeutic outcome in invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Fungal infections after bone marrow transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Radiologically guided fine needle lung biopsies in the evaluation of focal pulmonary lesions in allogeneic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Prediction of invasive pulmonary aspergillosis from colonisation of lower respiratory tract before marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Panfungal PCR assay for detection of fungal infection in human blood specimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

1 reference

7 January 2021

In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Surgical therapy for pulmonary aspergillosis in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Mini-allografts: ongoing trials in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Dendritic cell-mediated stimulation of the in vitro lymphocyte response to Aspergillus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703738

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703738

1 reference

Dimensions Publication ID

5 August 2017

1034251623

0 references

Fatcat ID

release_q4z2aehjsneadgoe3lzh7qxk5m

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q4z2aehjsneadgoe3lzh7qxk5m

24 November 2022

mapped directly with Wikidata item

1 reference